Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fluidigm Corp (NASDAQ:FLDM)

3.90
Delayed Data
As of Jun 23
 -0.20 / -4.88%
Today’s Change
3.54
Today|||52-Week Range
10.94
-46.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$114.3M

Company Description

Fluidigm Corp. engages in the development, manufacture, and market of microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Contact Information

Fluidigm Corp.
7000 Shoreline Court
South San Francisco California 94080
P:(650) 266-6000
Investor Relations:
(650) 243-6628

Employees

Shareholders

Other institutional54.15%
Mutual fund holders40.54%
Individual stakeholders29.14%

Top Executives

Stephen Christopher LinthwaitePresident, CEO, Chief Operating Officer & Director
Vikram JogChief Financial Officer
Nicholas S. KhadderSecretary & Chief Compliance Officer
Jennifer Ling LeePrincipal Accounting Officer, VP & Controller
Steven C. McPhailChief Commercial Officer